Zim Biosciences is developing innovative topical treatments for accelerating the healing of acute and chronic wounds by fortifying skin's integrity and augmenting the body's natural ability to heal itself.
Who Needs Us
The demand for advanced wound care products is expected to rise over the next 10 years, driven by growths in an aging population and an increase in lifestyle related disorders such as diabetes and obesity. The total advanced wound care market is predicted to be worth $16.3B in 2023.
Our product is anticipated to address multiple unmet medical needs including:
(1) improving skin integrity
(2) preventing wound infection
(3) preventing and managing scars
(4) speeding the generation of a viable wound bed
(5) preventing burn inflammation and injury progression
We plan on investigating our technology for skin integrity conditions (chronic wounds) such as skin tears and bedsores in the elderly and severe wounds (diabetic foot ulcers). Our long-term strategy is to advance surgical wound healing and battlefield care with our products.
Zim Biosciences has a patent-pending large molecule complex that had been commercialized on the consumer market. This dermatologically safe technology has demonstrated significantly faster healing and less scarring on damaged skin by advantageously retaining moisture in a nurturing environment. The Zim complex has the potential to be a platform molecule for a variety of skin related disorders.
(Co-Founder) President and CDO
(Co-Founder), Chairman of the Board